Evidence-basedEditor-reviewedCited sourcesUpdated regularly
Amino Acids & Proteins

Agmatine

Also known as: Agmatine sulfate, 4-Aminobutylguanidine, Decarboxylated arginine

The neurotransmitter-ish amino metabolite — a gym 'pump' staple with emerging pain and mood data on top.

  • By IngredientWiki Editorial Team
  • Fact-checked by IngredientWiki Editorial Team
  • Updated 2026-09-26
  • 2 min read

In short

Agmatine is a metabolite of the amino acid arginine, produced naturally in the brain, where it acts as a neuromodulator: it influences nitric-oxide signaling, blocks NMDA receptors, and modulates polyamine pathways. That unusual profile gives it three lives — as a sports 'pump' supplement (through nitric-oxide regulation), as a candidate for neuropathic pain relief (NMDA antagonism, supported by small trials), and as an adjunct in mood research (preclinical and early human data suggesting antidepressant-like activity). It is well tolerated at gram-level doses, with the main practical cautions being GI upset and additive effects with blood-pressure or pain medications.

  • Arginine metabolite; brain neuromodulator
  • Triple role: NO modulation, NMDA blockade, polyamine regulation
  • Small trials: neuropathic pain, mood support
  • Gym 'pump' use has plausible but thin evidence

What is Agmatine?

Agmatine is the amino-acid supplement with a neuroscience résumé. Made in the brain from arginine, it multitouches the systems supplement users care about: nitric oxide for the gym, NMDA receptors for pain, and monoamine pathways for mood. That breadth explains its cult status across three very different communities — lifters, pain patients, and biohackers — and its chronic problem: the evidence for each use is real but thinner than the enthusiasm. Agmatine is best understood as a promising, well-tolerated modulator with three modest claims and no single blockbuster.

Where it comes from

Natural sources

  • Endogenous metabolite of arginine via arginine decarboxylase
  • Present in fermented foods and some plants
  • Concentrated in brain regions involved in pain and mood

How it's made

Agmatine sulfate powder; typical doses 500 mg–2.5 g/day.

What it does in products

  • Nitric-oxide synthase modulation
  • NMDA-receptor antagonism
  • Polyamine pathway regulation
  • Imidazoline-receptor interaction

Benefits

Neuropathic pain support

moderate evidence

Small randomized trials (notably in lumbar-disc-associated radiculopathy) report pain reduction with agmatine sulfate, consistent with its NMDA-blocking mechanism.

Mood support

emerging evidence

Preclinical antidepressant-like activity is strong; early human data are limited but consistent in direction.

Exercise 'pump' and blood flow

emerging evidence

Mechanistically plausible through nitric-oxide modulation, but human performance trials are few and inconclusive.

Side effects & safety

GI upset at higher doses (uncommon)Typically mild; take with food.
Mild blood-pressure lowering (rare)Relevant only at higher doses or with antihypertensives.

Safety considerations

  • Avoid — insufficient data.
  • Antihypertensives — additive lowering possible
  • Pain medications and NMDA-acting drugs — additive effects; discuss combinations with a clinician
  • Not for: None absolute

How it's used

In supplements

500 mg–2.5 g/day, often divided; pain trials used ~2.67 g/day. Start at 500 mg and titrate.

In skincare

Not a topical ingredient.

Regulatory status

  • Sold as a dietary supplement; no FDA-approved disease claims.
  • Not applicable.

Popular products containing Agmatine

  • Nutricost Agmatine Sulfate — 1,000 mg capsulesNutricost · Supplement
  • BulkSupplements Agmatine Sulfate — Bulk powderBulkSupplements · Supplement
  • Nootropics Depot Agmatine Sulfate — Lab-tested powderNootropics Depot · Supplement

Product names and brands are shown for reference and belong to their respective owners.

The NMDA-pain connection

Chronic and neuropathic pain involves overactive NMDA receptors, the same target as ketamine and some nerve-pain drugs. Agmatine blocks NMDA signaling through a distinct binding mechanism, and the best human trial — in disc-related radiculopathy — showed meaningful pain relief. This is agmatine's most evidence-grounded use, though the trial base is small.

The pump paradox

Agmatine both stimulates and inhibits nitric-oxide synthase depending on context and timing — which makes 'pump' claims plausible but unpredictable. Users report better pumps anecdotally, but controlled performance data are scarce. The gym reputation currently outruns the literature.

Frequently asked questions

Is agmatine a stimulant?

No — it has no caffeine-like stimulation. Its effects are modulatory, building over days to weeks.

Can agmatine replace pain medication?

No — discuss with your clinician. It is best viewed as an adjunct for neuropathic-type pain under supervision.

Does agmatine interact with pre-workout nitric-oxide boosters?

Combining multiple NO-modulating supplements is common in the gym but poorly studied; start low and watch for blood-pressure changes.

The bottom line

Agmatine is a genuinely interesting neuromodulator with three modest claims — pain, mood, and pump — of which neuropathic pain carries the best evidence.

References

  1. Agmatine in neuropathic pain: clinical trial. Pain Medicine. https://pubmed.ncbi.nlm.nih.gov/20493424/
  2. Agmatine: pharmacology and therapeutic potential. PubMed Central. https://pubmed.ncbi.nlm.nih.gov/31726546/
  3. Agmatine and mood disorders. PubMed. https://pubmed.ncbi.nlm.nih.gov/28750504/